This Letter to the Editor highlights how the finding that LPS drives NSCLC progression may help explain recurring observations in the lung cancer - microbiome literature and proposes next steps, including exploration of specific microbial factors potentially regulated by the mechanisms described in Sha et al.'s article.
Angelakopoulou et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: